Bile Acid Activated Cell Signaling in the Liver and Nutrition
Bile Acid Activated Cell Signaling in the Liver and Nutrition
批准号:
7629638
负责人:
PHILLIP B HYLEMON
金额:
$28.64万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-21 至 2011-05-31
关键词:
ADP ribosylationAKT Signaling PathwayApoptosisBile AcidsBile fluidCYP7A1 geneCYP8B1 geneCell physiologyCeramidesCholestasisCholesterolChronicD CellsDataEGFR geneEndosomesEpithelial CellsExcisionFat-Soluble VitaminFistulaG Protein-Coupled Receptor GenesG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGallbladderGenesGenus ColaGrantHepatocyteIn VitroInsulinInsulin ReceptorIntestinesIntravenous infusion proceduresLipidsLipoproteinsLiverMAPK8 geneMessenger RNAModelingMolecularNecrosisNuclear ReceptorsPathway interactionsPertussis ToxinPhospholipidsProcessProtein Kinase CProteinsProto-Oncogene Proteins c-aktPublicationsRattusReceptor CellReportingResearch PersonnelRodentSignal PathwaySignal TransductionSignaling MoleculeSmall IntestinesSolutionsSpecificitySphingosineSteroidsStreamVitamin Dacidic sphingomyelinasebile saltscarcinogenesisceramide 1-phosphatecholangiocytecholesterol absorptioncholesterol controlcolon carcinogenesisgastrointestinal systemglucose metabolismin vivoinhibitor/antagonistinsightlipoprotein cholesterolliver metabolismmouse modelnutritionprogramspromoterreceptorsphingosine 1-phosphate
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Bile acids are steroid molecules that are synthesized from cholesterol in the liver hepatocytes. Their synthesis represents a major excretory pathway for removal of cholesterol from the body. Recent studies show that bile acids also function as powerful regulatory molecules helping to coordinately control cholesterol, lipoprotein, and glucose metabolism in the liver. Bile acids are able to regulate the expression of numerous genes and activities of proteins through 2 distinct, yet highly coordinated cellular mechanisms. They can activate specific nuclear receptors (i.e. FXR, PXR, Vitamin D) and cell signaling pathways (i.e. JNK1/2, ERK1/2, AKT, protein kinase C). Each bile acid appears to show some degree of specificity as to which nuclear receptor and cell signaling pathway that it activates, suggesting that the bile acid pool composition may be an important regulator of liver metabolism. The specific aims of the current grant renewal application are: 1) Determine the identity of the G protein coupled receptor(s) (GPCR), which transduces conjugated bile acid signaling in primary hepatocytes via ERBB1 and the insulin receptor, to ERK1/2 and AKT pathways. Determine the molecular mechanism(s) by which the pertussis toxin sensitive GPCR signal causes activation of ERBB1 and the insulin receptor in primary hepatocytes. 2) Determine the mechanism(s) of activation of the JNK1/2 pathway by bile acids in primary rodent hepatocytes and in vivo. Determine how different bile acids activate acidic sphingomyelinase (ASM) in vitro. 3). Characterize the activation of the JNK1/2, ERK1/2 and AKT signaling pathways by different bile acids in the chronic bile fistula rat and mouse models. Determine the effects of different bile acid infusion (IV and ID) on the activation of cell signaling pathways, levels of selected lipid signaling molecules, and mRNA levels of key genes involved in cholesterol and glucose metabolism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sphingolipids in alcoholic liver disease
-
批准号:10608594
-
项目类别:
-
资助金额:$52.31万
-
财政年份:2023
-
负责人:PHILLIP B HYLEMON
-
依托单位:
LncRNA H19 in Cholestatic Liver Diseases
-
批准号:10202570
-
项目类别:
-
资助金额:$53.65万
-
财政年份:2018
-
负责人:PHILLIP B HYLEMON
-
依托单位:
LncRNA H19 in Cholestatic Liver Diseases
-
批准号:10909545
-
项目类别:
-
资助金额:$62.96万
-
财政年份:2018
-
负责人:PHILLIP B HYLEMON
-
依托单位:
LncRNA H19 in Cholestatic Liver Diseases
-
批准号:9750721
-
项目类别:
-
资助金额:$53.65万
-
财政年份:2018
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis
-
批准号:9024718
-
项目类别:
-
资助金额:$41.17万
-
财政年份:2015
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Bile Acids and Clostridium scindens Inhibit C. difficile: Role of Secreted Antibacterial Compounds
-
批准号:9233344
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Role of Bile Acids and Gut Bacteria in GI Diseases
-
批准号:8698288
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Role of Bile Acids and Gut Bacteria in GI Diseases
-
批准号:8536579
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Role of Bile Acids and Gut Bacteria in GI Diseases
-
批准号:8324091
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:7035831
-
项目类别:
-
资助金额:$32.44万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:6799002
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:6861103
-
项目类别:
-
资助金额:$33.23万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:7189897
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:7371133
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
-
批准号:6369833
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
-
批准号:6524254
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid Metabolism
-
批准号:8824513
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
-
批准号:6787328
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
-
批准号:6661859
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
-
批准号:6931638
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
海外基金